Condensed Consolidated Statements of Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Other Comprehensive Loss [Member]	Total
Balance at Jun. 30, 2020	$ 26,032	$ 26,134,819	$ (21,176,799)	$ (125,038)	$ 4,859,014
Balance (in shares) at Jun. 30, 2020	26,032,263
Fair value of vested stock options		504,936			504,936
Fair value of vested restricted common stock	$ 163	280,985			281,148
Fair value of vested restricted common stock (in shares)	163,553
Repurchase of common stock	$ (67)	(150,319)			(150,386)
Repurchase of common stock (in shares)	(67,417)
Repurchase of stock options and warrants		(308,313)			(308,313)
Common stock issued upon exercise of stock options	$ 159	88,691			88,850
Common stock issued upon exercise of stock options (in shares)	158,609
Common stock issued upon exercise of warrants	$ 65	81,186			81,251
Common stock issued upon exercise of warrants (in shares)	65,000
Net income (loss) for the period			(196,213)		(196,213)
Foreign currency translation				3,348	3,348
Balance at Mar. 31, 2021	$ 26,352	26,631,985	(21,373,012)	(121,690)	5,163,635
Balance (in shares) at Mar. 31, 2021	26,352,008
Balance at Jun. 30, 2020	$ 26,032	26,134,819	(21,176,799)	(125,038)	4,859,014
Balance (in shares) at Jun. 30, 2020	26,032,263
Balance at Jun. 30, 2021	$ 26,498	26,982,052	(21,461,888)	(119,577)	5,427,085
Balance (in shares) at Jun. 30, 2021	26,498,215
Balance at Dec. 31, 2020	$ 26,266	26,709,401	(21,422,760)	(118,357)	5,194,550
Balance (in shares) at Dec. 31, 2020	26,266,008
Fair value of vested stock options		85,151			85,151
Fair value of vested restricted common stock	$ 20	94,174			94,194
Fair value of vested restricted common stock (in shares)	20,079
Repurchase of common stock	$ (11)	(23,101)			(23,112)
Repurchase of common stock (in shares)	(10,750)
Common stock issued upon exercise of stock options		(308,313)			(308,313)
Common stock issued upon exercise of warrants	$ 77	74,673			74,750
Common stock issued upon exercise of warrants (in shares)	76,671
Net income (loss) for the period			49,748		49,748
Foreign currency translation				(3,333)	(3,333)
Balance at Mar. 31, 2021	$ 26,352	26,631,985	(21,373,012)	(121,690)	5,163,635
Balance (in shares) at Mar. 31, 2021	26,352,008
Balance at Jun. 30, 2021	$ 26,498	26,982,052	(21,461,888)	(119,577)	5,427,085
Balance (in shares) at Jun. 30, 2021	26,498,215
Fair value of vested stock options		424,450			424,450
Fair value of vested restricted common stock	$ 293	446,140			446,433
Fair value of vested restricted common stock (in shares)	293,211
Repurchase of common stock	$ (34)	(82,019)			(82,053)
Repurchase of common stock (in shares)	(33,402)
Repurchase of stock options and warrants					0
Common stock issued upon exercise of stock options	$ 194	97,494			$ 97,688
Common stock issued upon exercise of stock options (in shares)	192,820				316,634
Common stock issued upon exercise of warrants	$ 50	59,450			$ 59,500
Common stock issued upon exercise of warrants (in shares)	50,000
Net income (loss) for the period			(1,194,117)		(1,194,117)
Foreign currency translation				(1,181)	(1,181)
Balance at Mar. 31, 2022	$ 27,001	27,927,567	(22,656,005)	(120,758)	5,177,805
Balance (in shares) at Mar. 31, 2022	27,000,844
Balance at Dec. 31, 2021	$ 26,817	27,475,741	(22,315,475)	(122,367)	5,064,716
Balance (in shares) at Dec. 31, 2021	26,817,056
Fair value of vested stock options		296,782			296,782
Fair value of vested restricted common stock	$ 42	102,410			102,452
Fair value of vested restricted common stock (in shares)	42,214
Repurchase of common stock	$ (6)	(14,235)			(14,241)
Repurchase of common stock (in shares)	(6,086)
Common stock issued upon exercise of stock options	$ 148	66,869			67,017
Common stock issued upon exercise of stock options (in shares)	147,660
Net income (loss) for the period			(340,530)		(340,530)
Foreign currency translation				1,609	1,609
Balance at Mar. 31, 2022	$ 27,001	$ 27,927,567	$ (22,656,005)	$ (120,758)	$ 5,177,805
Balance (in shares) at Mar. 31, 2022	27,000,844